Moderna leads development of mRNA vaccines in infectious diseases

Moderna leads development of mRNA vaccines in infectious diseases

Source: 
Biopharma Reporter
snippet: 

The global messenger ribonucleic acid (mRNA) vaccine market currently consists entirely of vaccines for COVID-19.